glp-1 agonist medications Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Researchers find GLP-1 medications safe

Network meta-analyses demonstrate a progressive efficacy gradient: GLP-1 monotherapy achieves approximately 7 kg weight reduction, dual agonists reach 11 kg, while triple agonists achieve up to 24 kg weight loss at 52 weeks [77]

There are various side-effects both mild and serious to taking GLP-1 drugs, including nausea and dizziness to pancreatitis and medullary thyroid cancer

Identification of N-terminally diversified GLP-1R agonists using saturation mutagenesis and chemical design

Supplements like fiber supplements, probiotics, and B vitamins can support digestive function and energy levels during the transition period

Exenatide inhibits the growth of endometrial cancer ishikawa xenografts in nude mice

People without diabetes often experience slightly greater weight loss than those with type 2 diabetes